Best mRNA / LNP CDMOs in United States

← All mRNA/LNP CDMOs Best Clean FDA History Commercial Scale

Region: USA Europe Asia

CDMOs tracked

Fully scored

With FDA records

FDA inspections

EMA/MHRA GMP certs

For US-manufactured mrna / lnp programs, Pfizer CentreOne, Aldevron, and FUJIFILM Diosynth Biotechnologies lead CDMO Signal's ranking of mrna / lnp CDMOs with confirmed US facilities. Filtered from the global directory of 36 scored mrna / lnp CDMOs to 18 with US manufacturing presence. US-based manufacturing carries specific advantages for sponsors filing under FDA jurisdiction: FDA inspection records — which form the core of the Signal Score's Quality Compliance pillar — apply directly, and QP release complexity common to EU-manufactured material does not apply. Rankings update as new inspection and certificate data enters the platform. Full methodology at cdmosignal.com/methodology.

mRNA and lipid nanoparticle (LNP) manufacturing scaled rapidly after COVID-19 vaccines and now supports therapeutics across rare disease, oncology, and infectious disease. The platform pairs IVT mRNA synthesis with LNP formulation — two distinct capability sets.

Choosing an mRNA/LNP CDMO depends on IVT scale, template strategy (linearized plasmid vs PCR), LNP formulation and microfluidics, and cold-chain handling. The rankings below score each CDMO on FDA inspections, GMP certification, clinical activity, and capacity.

FDA inspection outcomes across these CDMOs: 11 NAI (no action), 11 VAI (voluntary action), 0 OAI (official action). Leading inspection & GMP sites: United States (19), Denmark (17), Germany (15), Spain (13), Ireland (13).

Last updated 2026-07-11. Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

#	CDMO	Signal Score	Quality	FDA · GMP	Capacity	Programs
1	PC Pfizer CentreOne Kalamazoo, MI · McPherson, KS	91.5	100.0	4 insp · 17 GMP	—	363 programs
2	AE Aldevron Fargo, ND	85.3	100.0	1 insp · 0 GMP	—	0 programs
3	FD FUJIFILM Diosynth Biotechnologies Research Triangle, NC · Holly Springs, NC · Hillerod, DK	83.5	100.0	0 insp · 23 GMP	Expanding	0 programs
4	CD Corden Pharma Plankstadt, DE · Caponago, IT · Boulder, CO	82.5	99.7	3 insp · 10 GMP	—	0 programs
5	MR Moderna (Contract Mfg) Norwood, MA	81.8	100.0	2 insp · 4 GMP	—	10 programs
6	MK Merck KGaA / MilliporeSigma (CDMO) Darmstadt, DE · St. Louis, MO	81.8	98.6	2 insp · 2 GMP	—	22 programs
7	WK Wacker Biotech Jena, DE · Amsterdam, NL · San Diego, CA	81.6	100.0	0 insp · 13 GMP	—	0 programs
8	DH Danaher (CGT Portfolio) Washington, DC	81.5	—	—	—	0 programs
9	EK Evonik Health Care Birmingham, AL · Vancouver, BC	81.5	99.8	2 insp · 2 GMP	—	0 programs
10	ND Nitto Denko Avecia Milford, MA	80.3	100.0	2 insp · 0 GMP	—	0 programs
11	CRA Curia (RNA/Advanced) Albany, NY · Albuquerque, NM	79.4	99.9	2 insp · 16 GMP	—	0 programs
12	CA Catalent (Novo Holdings) Harmans, MD · Gosselies, BE	75.1	79.3	1 insp · 0 GMP	Available	0 programs
13	CG Cytiva (Mfg Services) Marlborough, MA · Uppsala, SE	74.0	—	—	—	0 programs
14	NR National Resilience San Diego, CA · Boston, MA · RTP, NC · Philadelphia, PA	73.4	97.7	1 insp · 0 GMP	Available	9 programs
15	LZ Lonza Biologics Houston, TX · Portsmouth, NH · Geleen, NL · Basel, CH	72.8	95.1	1 insp · 0 GMP	Limited	0 programs
16	TL TriLink BioTechnologies San Diego, CA	71.0	—	—	—	0 programs
17	AT Arcturus Therapeutics (Mfg) San Diego, CA	65.5	—	—	—	0 programs
18	UM MassBiologics Boston, MA	63.0	—	1 insp · 0 GMP	—	0 programs
—	PCI Pharma Services Philadelphia, PA	Profiled	—	—	—	0 programs
—	Porton Advanced Cranbury, NJ	Profiled	—	—	—	0 programs
—	Landmark Bio Watertown, MA	Profiled	—	—	—	0 programs
—	Phosphorex Hopkinton, MA	Profiled	—	—	—	0 programs

How we score CDMOs →

What to evaluate in a mRNA / LNP CDMO

IVT mRNA synthesis

Assess in-vitro transcription scale, capping strategy (co-transcriptional vs enzymatic), and template sourcing. These drive yield, purity, and cost.

LNP formulation

LNP encapsulation via microfluidics determines potency and tolerability. Confirm lipid sourcing, formulation freedom-to-operate, and particle-size control.

Plasmid / starting material

mRNA needs a DNA template. Check whether the CDMO supplies GMP plasmid in-house or coordinates a plasmid CDMO — it affects timelines.

Cold chain & stability

mRNA-LNP products are temperature-sensitive. Evaluate frozen storage, fill-finish, and the stability program.

FDA jurisdiction — how the ranking scores US-based CDMOs

The Signal Score's Quality Compliance pillar (35% of the composite) is dominated by FDA inspection data for US-based CDMOs: Establishment Inspection Report classifications (NAI, VAI, OAI), Form 483 observation counts, and Warning Letter history. For a CDMO whose primary facility footprint is US, this pillar carries direct weight — an inspection on the site slated for a sponsor's program applies without translation. For CDMOs with mixed US + international facility footprint, the ranking reflects the composite regulatory posture; sponsors evaluating for a specific program should verify inspection history on the exact US site under consideration via that CDMO's profile page.

Which US CDMOs also cover EU and UK regulatory geographies?

Many top-tier US-based CDMOs maintain EU (EMA) and UK (MHRA) GMP certification for facilities used to supply EU and UK trials or commercial markets. The Signal Score's Quality Compliance pillar includes EMA + MHRA certificate density as a component — a US-headquartered CDMO with dense EU/UK certificates typically ranks higher on this pillar than a US-only competitor. Sponsors running dual-jurisdiction programs should cross-check the individual CDMO profile pages for specific certificate coverage; the Europe region ranking surfaces CDMOs that also appear in the European jurisdiction ranking, indicating multi-region regulatory posture.

How CDMO Signal identifies US manufacturing presence

Region attribution is derived from each CDMO's declared facility locations in our directory. A CDMO's facility list is validated against corporate filings, press releases, and — where public — the FDA facility registration (FEI number lookups). Region matching is done at the country level: a US state name or two-letter abbreviation in the facility list places the CDMO in the US region. CDMOs with US + international sites appear in every applicable region ranking, which reflects operational reality — such a CDMO is a legitimate candidate for programs in any of those jurisdictions.

mRNA / LNP CDMOs — Frequently Asked Questions

Who are the top mRNA / LNP CDMOs?

By CDMO Signal's independent Signal Score, the top-ranked mRNA / LNP CDMOs include Pfizer CentreOne, Aldevron, FUJIFILM Diosynth Biotechnologies. See the full ranked table above — scored on FDA, clinical, financial, and capacity data.

How many mRNA / LNP CDMOs have FDA inspection records?

CDMO Signal tracks 12 mRNA / LNP CDMOs with FDA inspection records and 87 EMA/MHRA GMP certificates across the group.

What should I look for in an mRNA / LNP CDMO?

Look for proven IVT mRNA synthesis at your scale, LNP formulation via microfluidics, a clear template/plasmid supply strategy, cold-chain capability, and a clean FDA and EMA/MHRA record.

Do mRNA CDMOs also make the LNP and plasmid?

Capabilities vary. Some CDMOs offer end-to-end IVT mRNA, LNP formulation, and GMP plasmid; others specialize in one step and coordinate partners. Check each profile's modality coverage above.

Related modalities

Plasmid DNA CDMOs Lentiviral Vector CDMOs AAV / Gene Therapy CDMOs

Other Modalities

AAV CAR-T Lentiviral Cell Therapy Plasmid DNA Biologics Oligo/ASO Adenoviral Gene Editing Exosome Recombinant Proteins ADC